The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Die Kombinationstherapie des benignen Prostatasyndroms (BPS) mit α1-Blockern und 5α-Reduktase (5AR)-Inhibitoren wird basierend auf zwei Leitstudien zu Doxazosin/Finasterid und Tamsulosin/Dutasterid für alle 10 in Deutschland möglichen Kombinationen (5-mal α1-Blocker und 2-mal 5AR-Inhibitoren) empfohlen. Da in der BPS-Therapie in Deutschland Tamsulosin und Finasterid überwiegen, wurde die Rolle der...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.